Report overview
The global Veterinary Active Pharmaceutical Ingredients (API) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Chemical Based API Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Veterinary Active Pharmaceutical Ingredients (API) include Alivira Animal Health Ltd, Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Procyon Life Sciences, SUANFARMAOfichem Group, NGL Fine-Chem Ltd, Huvepharma, Jiangsu Lingyun Pharmaceutical Co. Ltd, Excel Veterinary HealthcareVetpharma(Insud Pharma) and Menadiona, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Active Pharmaceutical Ingredients are the substances used in the fabrication of pharmaceutical drugs responsible for beneficial health effects produced by use of the product. An example of an API in veterinary medicine would be trimethoprim-sulfadoxine contained in the products Borgal, Trivetrin, or Trimidox.
This report aims to provide a comprehensive presentation of the global market for Veterinary Active Pharmaceutical Ingredients (API), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Active Pharmaceutical Ingredients (API). This report contains market size and forecasts of Veterinary Active Pharmaceutical Ingredients (API) in global, including the following market information:
Global Veterinary Active Pharmaceutical Ingredients (API) Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Veterinary Active Pharmaceutical Ingredients (API) Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Veterinary Active Pharmaceutical Ingredients (API) companies in 2023 (%)
We surveyed the Veterinary Active Pharmaceutical Ingredients (API) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Active Pharmaceutical Ingredients (API) Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Veterinary Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Type, 2023 (%)
Chemical Based API
Biological API
Highly Potent APl(HPAPI)
Global Veterinary Active Pharmaceutical Ingredients (API) Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Veterinary Active Pharmaceutical Ingredients (API) Market Segment Percentages, by Application, 2023 (%)
CDMO
CMO
Global Veterinary Active Pharmaceutical Ingredients (API) Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Veterinary Active Pharmaceutical Ingredients (API) Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Active Pharmaceutical Ingredients (API) revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Veterinary Active Pharmaceutical Ingredients (API) revenues share in global market, 2023 (%)
Key companies Veterinary Active Pharmaceutical Ingredients (API) sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Veterinary Active Pharmaceutical Ingredients (API) sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alivira Animal Health Ltd
Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
Procyon Life Sciences
SUANFARMAOfichem Group
NGL Fine-Chem Ltd
Huvepharma
Jiangsu Lingyun Pharmaceutical Co. Ltd
Excel Veterinary HealthcareVetpharma(Insud Pharma)
Menadiona
lndukern Group
LasaSupergenerics Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Active Pharmaceutical Ingredients (API), market overview.
Chapter 2: Global Veterinary Active Pharmaceutical Ingredients (API) market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Active Pharmaceutical Ingredients (API) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
